Tricuspid	tricuspid	O	O	OTHERS	I
valve	valve	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
and	and	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
carbonate	carbonate	CHEMICALS	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
newborn	newborn	O	O	O	O
infant	infant	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
newborn	newborn	O	O	O	O
with	with	O	O	O	O
massive	massive	O	O	O	O
tricuspid	tricuspid	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
,	,	O	O	O	O
atrial	atrial	O	DISEASE	OTHERS	I
flutter	flutter	O	DISEASE	OTHERS	I
,	,	O	O	O	O
congestive	congestive	O	DISEASE	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
high	high	O	O	O	O
serum	serum	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
is	is	O	O	O	O
described	described	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
patient	patient	O	O	O	O
to	to	O	O	O	O
initially	initially	O	O	O	O
manifest	manifest	O	O	O	O
tricuspid	tricuspid	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
and	and	O	O	O	O
atrial	atrial	O	DISEASE	OTHERS	I
flutter	flutter	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
11th	11th	O	O	O	O
described	described	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
among	among	O	O	O	O
infants	infants	O	O	O	O
exposed	exposed	O	O	O	O
to	to	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
compounds	compounds	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
trimester	trimester	O	O	O	O
of	of	O	O	O	O
pregnancy	pregnancy	O	O	O	O
.	.	O	O	O	O

Sixty-three	sixty-three	O	O	O	O
percent	percent	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
infants	infants	O	O	O	O
had	had	O	O	O	O
tricuspid	tricuspid	O	O	O	O
valve	valve	O	O	O	O
involvement	involvement	O	O	O	O
.	.	O	O	O	O

Lithium	lithium	CHEMICALS	O	OTHERS	I
carbonate	carbonate	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
factor	factor	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
increasing	increasing	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
congenital	congenital	O	O	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
when	when	O	O	O	O
taken	taken	O	O	O	O
during	during	O	O	O	O
early	early	O	O	O	O
pregnancy	pregnancy	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
also	also	O	O	O	O
causes	causes	O	O	O	O
neurologic	neurologic	O	O	OTHERS	I
depression	depression	O	DISEASE	OTHERS	I
,	,	O	O	O	O
cyanosis	cyanosis	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
cardiac	cardiac	O	O	OTHERS	I
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
when	when	O	O	O	O
consumed	consumed	O	O	O	O
prior	prior	O	O	O	O
to	to	O	O	O	O
delivery	delivery	O	O	O	O
.	.	O	O	O	O

